BioAtla, Inc. (BCAB) Reports In-Line Q3 EPS

BioAtla, Inc. (NASDAQ: BCAB) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• SpaceX: New Street Research sees 22% upside from proposed IPO price
• Copa Holdings reports 17% increase in May passenger traffic